Edition:
United Kingdom

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

1.03USD
13 Sep 2019
Change (% chg)

$-0.05 (-4.63%)
Prev Close
$1.08
Open
$1.11
Day's High
$1.13
Day's Low
$1.01
Volume
234,281
Avg. Vol
210,277
52-wk High
$15.95
52-wk Low
$0.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 5.86 -1.208
Mar '19 5.04 -0.911
FY 2018 Dec '18 3.67 -0.993
Sep '18 1.63 -1.057
Jun '18 3.68 -1.009
Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 5.92 6.13 5.60 19.60
Quarter Ending Dec-19 5 6.10 6.80 5.60 21.70
Year Ending Dec-19 5 22.92 23.80 22.10 64.06
Year Ending Dec-20 5 27.34 35.51 21.40 167.73
Earnings (per share)
Quarter Ending Sep-19 4 -0.62 -0.54 -0.68 --
Quarter Ending Dec-19 4 -0.44 -0.16 -0.61 --
Year Ending Dec-19 3 -2.91 -2.07 -3.41 -3.51
Year Ending Dec-20 4 -1.90 -0.74 -2.70 -1.70
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.39 32.66
P/E High - Last 5 Yrs. -- 147.53 47.31
P/E Low - Last 5 Yrs. -- 47.83 23.88
Beta -- 1.08 0.89
Price to Sales (TTM) -- 49.44 7.91
Price to Book (MRQ) 4.39 10.14 5.38
Price to Tangible Book (MRQ) 4.93 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions 86.59 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.43 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago 2.93 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate -- 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 21.00 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.57 10.20
Total Debt to Equity (MRQ) 0.00 31.19 14.55
Interest Coverage (TTM) -- -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.09 52.24
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.43 13.12
Operating Margin (TTM) -- -183.67 6.81
Operating Margin - 5 Yr. Avg. -- -126.86 8.92
Pre-Tax Margin (TTM) -- -174.38 5.99
Pre-Tax Margin - 5 Yr. Avg. -- -132.62 9.22
Net Profit Margin (TTM) -- -181.07 2.63
Net Profit Margin - 5 Yr. Avg. -- -137.00 5.58
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,668,830 887,293,452
Net Income/Employee (TTM) -1,598,903 533,008 101,845,288
Receivable Turnover (TTM) -- 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.33 6.40 11.17
Return on Assets - 5 Yr. Avg. -- 5.50 12.34
Return on Investment (TTM) -38.27 8.95 14.48
Return on Investment - 5 Yr. Avg. -- 6.82 16.02
Return on Equity (TTM) -38.37 10.09 15.78
Return on Equity - 5 Yr. Avg. -- 8.46 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -2.89 99 98
13 Week -1.71 -6.50 99 95
26 Week -14.92 -21.38 99 97
52 Week 12.14 -4.95 99 71
YTD 1.73 -10.66 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.29%
# of Holders: 128
Total Shares Held: 37,350,714
3 Mo. Net Change: -26,289
# New Positions: 17
# Closed Positions: 29
# Increased Positions: 60
# Reduced Positions: 71
# Net Buyers: -11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.